CJC-1295 / Ipamorelin Blend

CJC-1295 (No DAC) and Ipamorelin are two peptides commonly studied together for their complementary effects on growth-hormone-related pathways. CJC-1295 is an analog of Growth Hormone–Releasing Hormone (GHRH) and is designed to stimulate the pituitary through GHRH receptors. Ipamorelin, a selective Growth Hormone Secretagogue, acts on a separate receptor family to promote growth hormone release through a ghrelin-mediated pathway. By engaging two distinct receptor systems, the CJC-1295 / Ipamorelin combination is investigated for its potential to enhance pulsatile growth hormone output and influence downstream signaling pathways tied to cellular repair, metabolism, and tissue homeostasis. Research exploring this peptide combination has examined…